Sarah Boyce
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sarah Boyce
Earlier roles on record: Board Member at Ligand Pharmaceuticals Inc (LGND) until November 1, 2022. Ligand Pharmaceuticals Inc reported in an 8-K filed November 4, 2022 that Sarah Boyce resigned as board of directors, effective November 1, 2022.
“On November 1, 2022, in connection with the Separation, Sarah Boyce, Jennifer Cochran and Sunil Patel each resigned from Ligand's board of directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2022-06-13–2022-11-01
-
2019-01-01–2022-11-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.